The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer Hirotsugu Kenmotsu, MD, Tateaki Naito, MD, Madoka.

Slides:

Advertisements

Similar presentations

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages

Advertisements

Polymyositis Associated With Severe Interstitial Lung Disease

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD

Interstitial Lung Disease Following Single-Agent Nanoparticle Albumin-Bound Paclitaxel Treatment in Patients with Advanced Non-Small Cell Lung Cancer -

Management of Myositis-Related Interstitial Lung Disease

Jeffrey Bradley, MD Journal of Thoracic Oncology

Sequential Immunologic Reactions after Suspension of Nivolumab Treatment in Lung Adenocarcinoma Patient Hiromichi Shirasu, MD, Akira Ono, MD, Toshiaki.

Acceleration of pulmonary interstitial fibrosis in a patient with myeloperoxidase- antineutrophil cytoplasmic antibody-positive erythema elevatum diutinum

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease Eisaku.

Diagnostic Approach to the Patient With Diffuse Lung Disease

Idiopathic Pulmonary Fibrosis: Current Concepts

Hironori Yoshida, MD, Young Hak Kim, MD Journal of Thoracic Oncology

Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD Journal of Thoracic Oncology

Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer

a-d) Typical changes over time in different diffuse lung diseases

Changes in high-resolution computed tomography (HRCT) pattern over time. a) Idiopathic pulmonary fibrosis (IPF), increased specificity over time. Changes.

Longitudinal imaging after initial diagnosis

Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A

Volume 145, Issue 3, Pages (March 2014)

Usual Interstitial Pneumonia Complicating Dyskeratosis Congenita

Idiopathic Pulmonary Fibrosis: Evolving Concepts

Characterization of Pneumonitis in Patients with Advanced Non-small Cell Lung Cancer Treated with Everolimus (RAD001) Dorothy A. White, MD, Lawrence.

Acute Exacerbation of Usual Interstitial Pneumonia After Resection of Lung Cancer Hiroaki Sugiura, MD, Atsuya Takeda, MD, PhD, Toshiko Hoshi, MD, PhD,

Michael E. Halkos, MD, Anthony A. Gal, MD, Faraz Kerendi, MD, Daniel L

Rheumatoid Arthritis-Associated Interstitial Lung Disease

Electronic Updates for JTO Readers

Ground glass opacity of the lung: The veil that needs lifting

Organizing Pneumonia Induced by Nivolumab in a Patient with Metastatic Melanoma Kazuhisa Nakashima, MD, Tateaki Naito, MD, Shota Omori, MD, Shusuke Yoshikawa,

An Unusual Presentation of Malignant Pleural Mesothelioma

Successful Crizotinib Retreatment after Crizotinib-Induced Interstitial Lung Disease Satoru Yanagisawa, MD, PhD, Akira Inoue, MD, PhD, Akira Koarai, MD,

Hironori Yoshida, MD, Young Hak Kim, MD Journal of Thoracic Oncology

Frank Detterbeck, MD Journal of Thoracic Oncology

Ziad Thotathil, MD, FRCR, Jeremy Long, FRACP

Successful Treatment with Erlotinib after Gefitinib-Induced Severe Interstitial Lung Disease Masayuki Takeda, MD, PhD, Isamu Okamoto, MD, PhD, Chihiro.

Evaluation of the Recommended Dose and Efficacy of Amrubicin as Second- and Third- Line Chemotherapy for Small Cell Lung Cancer Satoshi Igawa, MD, PhD,

Ritbune Prakobkit, MD, William Churk-Nam Auyeung, MD

Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival after Stereotactic Body Radiation Therapy for Lung Cancer Nami.

Diagnosis of Interstitial Lung Diseases

Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer Tateaki Naito, MD, PhD, Fumihiro Tanaka, MD, PhD, Akira Ono, MD,

Awake Thoracoscopic Biopsy of Interstitial Lung Disease

Rubinowitz Ami N. , MD, Moon Marianne , MD, Homer Robert , MD, PhD

Phase I and Pharmacokinetic Study of Combination Chemotherapy Using Irinotecan and Paclitaxel in Patients with Lung Cancer Gyo Asai, MD, PhD, Nobuyuki.

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response

Multiplexed Molecular Profiling of Lung Cancer Using Pleural Effusion

Disease Control as a Predictor of Survival with Gefitinib and Docetaxel in a Phase III Study (V-15-32) in Advanced Non-small Cell Lung Cancer Patients

Jennifer L. Dallas, MD, Michael A. Jantz, MD, Judith L

Nonspecific interstitial pneumonia: high-resolution computed tomography images from a 46-year-old male patient who underwent lung transplantation. a) The.

Nasion Swelling as the Presenting Symptom of Lung Adenocarcinoma

Mirror Mirror on the Wall, Who Is the Fairest of Them All

Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-small Cell Lung Cancer Hong Kwan Kim, MD, Yong Soo Choi,

Shih-Chieh Chang, Cheng-Yu Chang, Chiung-Yu Chen, Chong-Jen Yu

Jeffrey Bradley, MD Journal of Thoracic Oncology

Multiple Pulmonary Nodules in an Elderly Woman

Pulmonary Hypertension in Patients With Interstitial Lung Diseases

Pattern high-resolution computed tomography consistent with nonspecific interstitial pneumonia in a patient with histological diagnosis of usual interstitial.

Evaluation of acute symptoms

T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)

Two Generations of Light/Never-Smokers With Advanced Adenocarcinoma of the Lung with Durable Responses to Erlotinib Nathan A. Pennell, MD, PhD, Lihong.

Giant Desmoid Tumor of the Chest Wall

COUNTERPOINT: Does Interstitial Pneumonia With Autoimmune Features Represent a Distinct Class of Patients With Idiopathic Interstitial Pneumonia? No

European Lung Cancer Conference (ELCC) 2016 Organisation

Recurrent Primary Synovial Sarcoma of the Chest Wall

Metastatic Lung Cancer to the Pancreas

S-1 Treatment for Chemorefractory Thymic Carcinoma

A) Axial and b) coronal computed tomography scans of usual interstitial pneumonia pattern in a patient with rheumatoid arthritis. a) Axial and b) coronal.

Acute Exacerbation of Interstitial Fibrosis After Pulmonary Resection

Thymic Small Cell Carcinoma Shows Marked Response to Amrubicin

High-resolution computed tomography scan demonstrating a typical example of usual interstitial pneumonia pattern with honeycombing change and traction.

A Review of First-Line Treatment for Small-cell Lung Cancer

Robert Comis, MD, The Passing of a “Lung Man”

Presentation transcript:

The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer Hirotsugu Kenmotsu, MD, Tateaki Naito, MD, Madoka Kimura, MD, Akira Ono, MD, Takehito Shukuya, MD, Yukiko Nakamura, MD, Asuka Tsuya, MD, Kyoichi Kaira, MD, Haruyasu Murakami, MD, Toshiaki Takahashi, MD, Masahiro Endo, MD, Nobuyuki Yamamoto, MD Journal of Thoracic Oncology Volume 6, Issue 7, Pages 1242-1246 (July 2011) DOI: 10.1097/JTO.0b013e318216ee6b Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 High-resolution computed tomography (HRCT) image of the chest. A, Pretreatment HRCT image of the chest showing subpleural distribution, honeycombing, traction bronchiectasis, and architectural distortion (UIP pattern). B, HRCT image of the chest showing ground-glass abnormality superimposed on pretreatment interstitial shadow (chemotherapy-related exacerbation of ILD). C, Pretreatment HRCT image of the chest showing patchy ground-glass opacity with reticulation, traction bronchiectasis, and architectural distortion (non-UIP pattern). UIP, usual interstitial pneumonia; ILD, interstitial lung disease. Journal of Thoracic Oncology 2011 6, 1242-1246DOI: (10.1097/JTO.0b013e318216ee6b) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions